Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim D Janda

Showing results (331-340 of 342) with videos related to

Pageof 35
Sort By:
Human Gene Therapy|April 11, 2012
AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behaviorJonathan B Rosenberg, Martin J Hicks, Bishnu P De, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 11, 2013
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporterAnat Maoz, Martin J Hicks, Shankar Vallabhjosula, et al.
Science (New York, N.Y.)|March 1, 2008
Deeply inverted electron-hole recombination in a luminescent antibody-stilbene complexErik W Debler, Gunnar F Kaufmann, Michael M Meijler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 6, 2011
Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugsMartin J Hicks, Bishnu P De, Jonathan B Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2007
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonistsLisa M Eubanks, Mark S Hixon, Wei Jin, et al.
Human Gene Therapy. Clinical Development|March 22, 2014
Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccineMartin J Hicks, Stephen M Kaminsky, Bishnu P De, et al.
Angewandte Chemie (International Ed. in English)|April 2, 2020
Discovery of Chemicals to Either Clear or Indicate Amyloid Aggregates by Targeting Memory-Impairing Anti-Parallel Aβ DimersJinny Claire Lee, Hye Yun Kim, Sejin Lee, et al.
Bioorganic & Medicinal Chemistry|June 15, 2021
Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assayRyan J Shirey, Jonathan R Hart, BanuPriya Sridharan, et al.
The Journal of Biological Chemistry|August 9, 2006
N-(3-oxo-acyl)homoserine lactones signal cell activation through a mechanism distinct from the canonical pathogen-associated molecular pattern recognition receptor pathwaysVladimir V Kravchenko, Gunnar F Kaufmann, John C Mathison, et al.
Communications Biology|May 25, 2024
Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat dietAndrás H Lékó, Adriana Gregory-Flores, Renata C N Marchette, et al.
Pageof 35

Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
Human Gene Therapy|April 11, 2012
AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behaviorJonathan B Rosenberg, Martin J Hicks, Bishnu P De, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 11, 2013
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporterAnat Maoz, Martin J Hicks, Shankar Vallabhjosula, et al.
Science (New York, N.Y.)|March 1, 2008
Deeply inverted electron-hole recombination in a luminescent antibody-stilbene complexErik W Debler, Gunnar F Kaufmann, Michael M Meijler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 6, 2011
Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugsMartin J Hicks, Bishnu P De, Jonathan B Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2007
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonistsLisa M Eubanks, Mark S Hixon, Wei Jin, et al.
Human Gene Therapy. Clinical Development|March 22, 2014
Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccineMartin J Hicks, Stephen M Kaminsky, Bishnu P De, et al.
Angewandte Chemie (International Ed. in English)|April 2, 2020
Discovery of Chemicals to Either Clear or Indicate Amyloid Aggregates by Targeting Memory-Impairing Anti-Parallel Aβ DimersJinny Claire Lee, Hye Yun Kim, Sejin Lee, et al.
Bioorganic & Medicinal Chemistry|June 15, 2021
Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assayRyan J Shirey, Jonathan R Hart, BanuPriya Sridharan, et al.
The Journal of Biological Chemistry|August 9, 2006
N-(3-oxo-acyl)homoserine lactones signal cell activation through a mechanism distinct from the canonical pathogen-associated molecular pattern recognition receptor pathwaysVladimir V Kravchenko, Gunnar F Kaufmann, John C Mathison, et al.
Communications Biology|May 25, 2024
Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat dietAndrás H Lékó, Adriana Gregory-Flores, Renata C N Marchette, et al.
Pageof 35